SUBSCRIBE
SUBSCRIBE

Epic Bio

NEWS
Pictured: DNA with methyl marks over DNA sequence
Drug Development
Epigenetic Editing Explodes on the Heels of Gene Editing Success
Ubiquitous potential, possible safety advantages and the recent growth of cell and gene therapy are driving investment in a different type of genetic editing.
March 21, 2024
 · 
6 min read
 · 
Heather McKenzie
IN THE PRESS
Biotech Bay
Epic Bio to Participate in a Fireside Chat at the Canaccord Genuity Genetic Medicine for Generalists
April 10, 2024
 · 
1 min read
Biotech Bay
Epic Bio Announces Robust Slate of Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
April 9, 2024
 · 
2 min read
Biotech Bay
Epic Bio to Participate in a Fireside Chat at the Cantor Virtual Muscular Dystrophy Symposium
April 1, 2024
 · 
1 min read
Biotech Bay
Epic Bio to Present at the Upcoming Charles River Cell and Gene Therapy Summit
March 13, 2024
 · 
1 min read
Biotech Bay
Epic Bio to Present at the Upcoming CRISPR2.0 Conference
November 21, 2023
 · 
1 min read
Biotech Bay
FDA Grants Orphan Drug Designation to EPI-321, Epic Bio’s Novel Genetic Medicine Candidate for Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)
November 16, 2023
 · 
3 min read
Biotech Bay
Epic Bio to Participate in Upcoming November 2023 Investor Conference
November 7, 2023
 · 
1 min read
Drug Development
Epic Bio Reports New Data on Hypercompact Cas Proteins Optimized for Broad Therapeutic Applicability
October 26, 2023
 · 
2 min read
Biotech Bay
Epic Bio to Present at the Upcoming Annual European Society of Gene and Cell Therapy
October 19, 2023
 · 
1 min read
Business
Epic Bio Announces the Appointment of Weston Miller, M.D., as Chief Medical Officer
October 17, 2023
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2023
JOBS